Simultaneously, Mr. Hofer took on the role of CEO of Redox, a .406 portfolio company. Prior to his time at Optum, Mr. Hofer held leadership positions at CVS Health and UnitedHealth Group, according to a Nov. 15 .406 Ventures news release.
In his new role, Mr. Hofer will work to advise portfolio companies and identify investment opportunities. The venture firm focuses on early-stage investments in healthcare, data, cybersecurity and artificial intelligence companies.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
